ty -jour t1-预性和广泛耐药性结核病的新定义：世界卫生组织JF的更新 - 欧洲呼吸杂志JO -EUR RESSIR J DO -10.1183/13993003.00361-2021AU - Viney, Kerri AU - Linh, Nguyen Nhat AU - Gegia, Medea AU - Zignol, Matteo AU - Glaziou, Philippe AU - Ismail, Nazir AU - Kasaeva, Tereza AU - Mirzayev, Fuad Y1 - 2021/04/01 UR -//www.qdcxjkg.com/content/57/4/4/2100361.abstract N2-多龙 - 耐药性结核病（MDR-TB），定义为结核分枝杆菌，至少具有至少Isoniaiazid和Rifampicin [1]1990年代全球对结核病（TB）控制的威胁[2]。这种形式的结核病需要使用二线药物，这些药物比一线基于异辛酶和基于利福平的方案更有效，毒性和成本更高。MDR-TB是最早提醒全球国家当局的传染病之一，以了解抗微生物抗性作为未来的公共卫生挑战，进一步强调了美国和欧洲的MDR-TB爆发[3-5]。认识到这一新兴问题的全球重要性，世界卫生组织（WHO）于1996年发布了有关耐药结核病管理的第一项指南，自[1，6]以来定期对其进行更新。世界卫生组织和预性药物耐药性结核病已被定义为https://bit.ly/30fdffcwe要确认并感谢这次会议的两个共同主席Mario Raviglione和Jeremiah Chakaya，以及作为参加会议并为讨论做出贡献的众多专家。The meeting participants were: Charles Daley, Anneke Hesseling, Carole Mitnick, Zarir Udwadia, Christoph Lange, Giovanni Battista Migliori, Mario Raviglione, Olivia Keiser, Janne Estill, Simon Tiberi, Francesca Conradie, Keertan Dheda, Jonathon Campbell, Norbert Ndjeka, Irina Vasilyeva, Yuhong Liu, Kuldeep Sachdeva, Julia Rios, Tutik Ku​​smiati, Alena Skrahina, Thandar Hmun, Lucica Ditiu, Morten Ruhwald, Cathy Hewison, Agnes Gebhard, Kobto Koura, Draurio Barreira, Mohammed Yassin, Marlena Kaczmarek, Mukadi Ya Diul, Charles Wells, Mel Spigelman, Daniela Cirillo, Harald Hoffmann, Dissou Affolabi, Moses Joloba, Rumina Hassan, Vithal Prasad Myneedu, Renzong Li, Diana Vakhrusheva, Lindsay McKenna, Jamilya Ismoilova, Angela Starks, Heather Alexander, Sarabjit Chadha and Jeremiah Chakaya Muhwa. In addition, we thank the WHO staff who attended this meeting: Tauhid Islam, Mukta Sharma, Vineet Bhatia, Askar Yedilbayev, Rafael Lopez Olarte, Muhammad Akhtar, Jean Louis Abena Foe, Michel Gasana, Tereza Kasaeva, Matteo Zignol, Fuad Mirzayev, Medea Gegia, Linh Nguyen, Kerri Viney, Dennis Falzon, Ernesto Jaramillo, Nazir Ismail, Philippe Glaziou, Anna Dean, Marek Lalli, Marie-Christine Bartens, Nick Argent, Kitty van Weezenbeek, Olga Tosas Auguet and Kyung Hyun Oh. ER -